Our thinking.
Tarleton welcomes new client VentriJect
VentriJect, a Danish MedTech company, have appointed Tarleton Communications to handle its public relations in the UK and EU.
Director and Discipline: Do you have a communications strategy?
Thomas Averre is a Director at Tarleton Communications, a specialist life sciences public relations agency and writes about what a communications strategy is and why businesses should have one.
Oxford NHSFT Workshop
News - Tarleton Communications were invited to run a workshop for Oxford University Hospitals NHS Foundation Trust's innovation incubator, 'The Hill' on ‘Creating a brand’ today. We presented to the 2023 cohort on the importance of creating a brand and how they could go about doing it.
Why you don’t need to be using Threads (yet)
Threads may be the talk of the town, but there are many reasons why putting resource into this platform doesn't make sense for life science or engineering businesses.
What do the Mansion House reforms mean for your communications?
What do the Mansion House pension reforms mean for innovation-led businesses and how should they adapt their investor communications to reflect this?
MedTech Innovation Expo 2023
News - We were delighted to be invited to present a session on investor communications at this year’s Med Tech Innovation Expo at the NEC in Birmingham. Med Tech Innovation Expo is the UK’s leading exhibition for the medical technology sector.
The investment paradox: How can start-ups crack it?
Thomas Averre, founder of specialist public relations consultancy Tarleton Communications, provides a small preview of his upcoming seminar at Med-Tech Innovation Expo 2023 as he discusses how start-ups can go about securing investment.